Silotime-M 50 Tablet

Introduction

Silotime-M is a prescription medication that combines two active ingredients, Mirabegron and Silodosin. Mirabegron is a beta-3 adrenergic agonist, while Silodosin is an alpha-1 adrenergic antagonist. This medication is primarily used to treat symptoms of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in adult men.

Uses

Silotime-M is prescribed to manage the symptoms of overactive bladder (OAB) and benign prostatic hyperplasia (BPH). OAB is a condition characterized by a sudden and frequent urge to urinate, often accompanied by urinary incontinence. BPH, on the other hand, refers to an enlarged prostate gland that can cause difficulty in urination, weak urine flow, and frequent urination.

Dosage and Administration

follow the dosage instructions provided by your healthcare professional. The recommended dose of Silotime-M is usually one tablet taken orally once daily. The tablet should be swallowed whole with a glass of water, and it can be taken with or without food. Do not crush or chew the tablet as it may affect the way the medication is released in the body.

Mechanism of Action

Silotime-M works by targeting specific receptors in the body to help alleviate the symptoms of overactive bladder and benign prostatic hyperplasia. Mirabegron, a beta-3 adrenergic agonist, helps relax the smooth muscles of the bladder, reducing the frequency and urgency of urination. Silodosin, an alpha-1 adrenergic antagonist, works by relaxing the muscles in the prostate and bladder neck, improving urine flow and reducing the symptoms associated with an enlarged prostate.

Side Effects

Common side effects may include headache, dizziness, nausea, constipation, diarrhea, and dry mouth. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as difficulty breathing, chest pain, rapid heartbeat, or swelling of the face, lips, or tongue, seek immediate medical attention.

Drug Interactions

Silotime-M may interact with certain medications, including but not limited to other alpha-blockers, certain antifungals, and certain antibiotics. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. They can provide guidance on potential interactions and adjust your treatment plan accordingly.

Precautions

Before taking Silotime-M, inform your healthcare professional about any pre-existing medical conditions, including liver or kidney problems, heart conditions, and allergies. This medication may not be suitable for everyone, and your healthcare professional will evaluate the potential risks and benefits before prescribing it to you. Avoid alcohol and grapefruit juice while taking Silotime-M, as they may interact with the medication and increase the risk of side effects.

Storage

Patient Tips

• Take Silotime-M exactly as prescribed by your healthcare professional.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not stop taking Silotime-M without consulting your healthcare professional, even if you feel better.
• It may take some time before you notice the full benefits of the medication. Be patient and continue taking it as directed.
• If you have any questions or concerns about Silotime-M or its usage, consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Mirabegron: medicine to treat the symptoms of an overactive bladder (NHS UK) [Accessed 6 Jun. 2024] (online) Available at:
• Betmiga 25 mg prolonged-release tablets (Health Professionals SmPC) Available at:
• Mirabegron (Drugs.com) [Accessed 5 Jun. 2024] (online) Available at:
• myrbetriq (mirabegron) (RX) [Accessed 13 Jun. 2024] (online) Available at:
• Mirabegron (MedlinePlus) [Accessed 30 Jun. 2024] (online) Available at:
• Keam SJ. Mirabegron: Pediatric First Approval. Paediatr Drugs. 2021 Jul;23(4):411-415. doi: 10.1007/s40272-021-00452-4. [Accessed 4 Jun. 2024] Available at: